AcariaHealth Honored with Community Leader of the Year Award from The American Liver Foundation's Greater New York Division
AcariaHealth™, a national comprehensive specialty pharmacy, has been awarded the Community Leader of the Year Award by The American Liver Foundation's Greater New York Division. The award honors outstanding leaders in health care who work to change the course of liver disease.
AcariaHealth provides services for specialty disease states, such as liver disease and hepatitis C, which include care management, clinical programs, data capture and analysis, and patient care services. AcariaHealth is part of Envolve’s family of health solutions, including its full-service pharmacy benefit management division.
“AcariaHealth has been a long-time supporter of The American Liver Foundation and a critical partner to liver patients across the US,” said Thomas Nealon III, National Board Chair & CEO, American Liver Foundation. “For those battling liver disease, especially those living with hepatitis C, AcariaHealth has gone the extra mile to be a strong and forceful advocate for those individuals with patient support services, coordination of nursing services, and invaluable assistance with health insurance and financial issues. The dedicated team at AcariaHealth has supported our activities assisting liver patients and their families. They truly epitomize caring and commitment to the patient community. AcariaHealth is most deserving of the 2016 Community Leader of the Year award.”
“It’s a true honor for us to be recognized by The American Liver Foundation for our joint commitment to serving patients with liver disease,” said Carmen Fontanez, Executive Vice President of Envolve’s Pharmacy Solutions division. “We work hard to ensure that our specialty pharmacy services are designed to support patients with liver disease and other conditions through an enhanced level of care and support.”
The American Liver Foundation provides research, education, advocacy and support for 30 million Americans affected by liver disease. The award was presented at the Foundation’s Annual Honors Gala, bringing together influential medical professionals, physicians, and business leaders in Greater New York City, Long Island, and Northern New Jersey.